The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 6
  • 1
    Phelps, Charlotte Anne
    Chief Executive Officer born in July 1964
    Individual (5 offsprings)
    Officer
    2023-06-16 ~ now
    OF - director → CIF 0
  • 2
    Mr Frederik Dag Arfst Paulsen
    Born in October 1950
    Individual (10 offsprings)
    Person with significant control
    2019-12-19 ~ now
    PE - Has significant influence or controlCIF 0
  • 3
    Stephens, Benedict
    Individual (11 offsprings)
    Officer
    2023-08-31 ~ now
    OF - secretary → CIF 0
  • 4
    Clark, Graham James
    Chief Financial Officer born in April 1982
    Individual (3 offsprings)
    Officer
    2023-06-16 ~ now
    OF - director → CIF 0
  • 5
    Lofgren, Anders Theodor
    Vice President Northern Europe born in August 1959
    Individual (1 offspring)
    Officer
    2023-06-16 ~ now
    OF - director → CIF 0
  • 6
    41, Siriusdreef, 2132 Wt Hoofddorp, Netherlands
    Corporate (1 offspring)
    Person with significant control
    2024-05-31 ~ now
    PE - Ownership of shares – 75% or moreCIF 0
Ceased 15
  • 1
    Andrews, David Charles
    Individual
    Officer
    2020-02-06 ~ 2023-08-31
    OF - secretary → CIF 0
  • 2
    Rebours-mory, Veronique Marie, Madeleine, Michele
    Vice President born in July 1963
    Individual
    Officer
    2017-01-31 ~ 2021-02-18
    OF - director → CIF 0
  • 3
    Sempere, Thierry
    Director Of Operations born in March 1962
    Individual
    Officer
    2019-09-09 ~ 2021-04-16
    OF - director → CIF 0
  • 4
    De La Rubia, Enrique Rodriguez
    Chief Financial Officer born in July 1977
    Individual
    Officer
    2021-04-17 ~ 2023-06-17
    OF - director → CIF 0
  • 5
    Lumbroso, Alexandre Benjamin
    Consultant born in December 1926
    Individual
    Officer
    1998-11-30 ~ 2002-04-15
    OF - director → CIF 0
  • 6
    Talla, Rita
    Individual
    Officer
    2015-11-11 ~ 2018-06-25
    OF - secretary → CIF 0
  • 7
    Donovan, Brian, Dr
    Medical Advisor born in March 1935
    Individual (1 offspring)
    Officer
    2002-04-11 ~ 2008-03-12
    OF - director → CIF 0
    Donovan, Brian, Dr
    Consultant born in March 1935
    Individual (1 offspring)
    2017-01-31 ~ 2017-12-31
    OF - director → CIF 0
  • 8
    Schram, Hans
    Chemist born in January 1953
    Individual (1 offspring)
    Officer
    2002-04-11 ~ 2019-09-10
    OF - director → CIF 0
  • 9
    Tupholme, Michael Edward
    Pharmacist born in January 1937
    Individual
    Officer
    ~ 1998-06-30
    OF - director → CIF 0
  • 10
    Bratt, Anthony Brian
    General Manager born in July 1964
    Individual (6 offsprings)
    Officer
    2017-01-31 ~ 2020-03-02
    OF - director → CIF 0
    Bratt, Anthony Brian
    Individual (6 offsprings)
    Officer
    2018-06-25 ~ 2020-02-06
    OF - secretary → CIF 0
  • 11
    Mella, Rafael Guillermo
    Vice President Southern & Western Europe born in February 1967
    Individual
    Officer
    2021-02-18 ~ 2023-06-17
    OF - director → CIF 0
  • 12
    Dowling, Geoffrey Paul
    Individual (5 offsprings)
    Officer
    2003-07-16 ~ 2015-11-11
    OF - secretary → CIF 0
  • 13
    Hobbs, Jeffrey David
    Economist born in June 1942
    Individual (6 offsprings)
    Officer
    ~ 1999-05-31
    OF - director → CIF 0
    Hobbs, Jeffrey David
    Individual (6 offsprings)
    Officer
    ~ 1999-01-18
    OF - secretary → CIF 0
  • 14
    Mourik, Dick
    Individual
    Officer
    1999-01-18 ~ 2003-07-16
    OF - secretary → CIF 0
  • 15
    ARAMBY CONSULTANTS LIMITED
    Suite 1, Unit A1, Tectonic Place, Holyport Road, Maidenhead, Berkshire, United Kingdom
    Dissolved corporate (2 parents)
    Equity (Company account)
    340,782 GBP2018-03-31
    Officer
    2008-03-12 ~ 2016-11-23
    PE - director → CIF 0
parent relation
Company in focus

NORDIC PHARMA LIMITED

Previous name
NORDIC PHARMACEUTICALS LIMITED - 2002-05-07
Standard Industrial Classification
46460 - Wholesale Of Pharmaceutical Goods
Brief company account
Debtors
2,509,169 GBP2023-12-31
1,471,478 GBP2022-12-31
Cash at bank and in hand
142 GBP2023-12-31
0 GBP2022-12-31
Current Assets
4,612,601 GBP2023-12-31
2,480,633 GBP2022-12-31
Creditors
Current, Amounts falling due within one year
-4,444,326 GBP2023-12-31
-1,959,869 GBP2022-12-31
Net Current Assets/Liabilities
168,275 GBP2023-12-31
520,764 GBP2022-12-31
Net Assets/Liabilities
32,007 GBP2023-12-31
337,145 GBP2022-12-31
Equity
Called up share capital
200,000 GBP2023-12-31
200,000 GBP2022-12-31
Retained earnings (accumulated losses)
-167,993 GBP2023-12-31
137,145 GBP2022-12-31
Equity
32,007 GBP2023-12-31
337,145 GBP2022-12-31
Average Number of Employees
292023-01-01 ~ 2023-12-31
202022-01-01 ~ 2022-12-31
Trade Debtors/Trade Receivables
Current
1,868,163 GBP2023-12-31
1,392,634 GBP2022-12-31
Amounts Owed By Related Parties
357,087 GBP2023-12-31
Current
0 GBP2022-12-31
Other Debtors
Amounts falling due within one year
161,620 GBP2023-12-31
62,644 GBP2022-12-31
Debtors
Current, Amounts falling due within one year
2,386,870 GBP2023-12-31
1,455,278 GBP2022-12-31
Other Debtors
Amounts falling due after one year
122,299 GBP2023-12-31
16,200 GBP2022-12-31
Bank Borrowings/Overdrafts
Current
1,266,465 GBP2023-12-31
1,045,020 GBP2022-12-31
Trade Creditors/Trade Payables
Current
261,281 GBP2023-12-31
57,464 GBP2022-12-31
Amounts owed to group undertakings
Current
1,685,591 GBP2023-12-31
248,861 GBP2022-12-31
Other Taxation & Social Security Payable
Current
428,382 GBP2023-12-31
373,942 GBP2022-12-31
Other Creditors
Current
802,607 GBP2023-12-31
234,582 GBP2022-12-31
Creditors
Current
4,444,326 GBP2023-12-31
1,959,869 GBP2022-12-31
Future Minimum Lease Payments Under Non-cancellable Operating Leases
593,371 GBP2023-12-31
120,513 GBP2022-12-31

Related profiles found in government register
  • NORDIC PHARMA LIMITED
    Info
    NORDIC PHARMACEUTICALS LIMITED - 2002-05-07
    Registered number 01489084
    Building 1410 Arlington Business Park, Theale, Reading RG7 4SA
    Private Limited Company incorporated on 1980-04-02 (45 years 2 months). The company status is Active.
    The last date of confirmation statement was made at 2024-05-04
    CIF 0
  • NORDIC PHARMA LIMITED
    S
    Registered number 01489084
    Building 1410, Arlington Business Park, Theale, Reading, England, RG7 4SA
    Limited Company in Companies House, England
    CIF 1 CIF 2
  • NORDIC PHARMA LIMITED
    S
    Registered number 01489084
    Building 1410, Arlington Business Park, Theale, Reading, United Kingdom, RG7 4SA
    Limited Company in Companies House, England
    CIF 3
child relation
Offspring entities and appointments
Active 3
  • 1
    St Stephens House, Arthur Road, Windsor, Berkshire, England
    Corporate (4 parents)
    Equity (Company account)
    3,306,312 GBP2023-12-31
    Person with significant control
    2024-07-12 ~ now
    CIF 1 - Ownership of shares – 75% or moreOE
  • 2
    St Stephens House, Arthur Road, Windsor, Berkshire, England
    Corporate (7 parents)
    Person with significant control
    2024-06-30 ~ now
    CIF 3 - Ownership of shares – 75% or moreOE
  • 3
    St Stephens House, Arthur Road, Windsor, Berkshire, England
    Corporate (4 parents, 1 offspring)
    Equity (Company account)
    2,260,848 GBP2023-12-31
    Person with significant control
    2024-07-12 ~ now
    CIF 2 - Ownership of shares – 75% or moreOE
© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.